ScreenerHero
AMSAdvanced Medical Solutions Group plc
LSE · GB · Healthcare · Medical Instruments & Supplies · admedsol.com
281.50GBP0.00%Mkt Cap: 785.67M $P/E: 56.30

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Société anonyme
$81.53BUSDP/E 30.5
BOX
Becton, Dickinson and Company
$49.98BUSDP/E 34.1
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon Inc.
$32.44BUSDP/E 55.0
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech S.A.
$20.46BUSDP/E 64.5
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$16.89BUSDP/E 40.2
SRT
Sartorius Aktiengesellschaft
$14.73BUSDP/E 69.1
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0

Key Statistics

Company
Market Cap785.67M $
Enterprise Value861.59M $
Revenue (TTM)293.64M $
Gross Profit156.66M $
Net Income (TTM)12.77M $
Revenue/Share1.362 USD
Last Price281.50 GBP
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1.8K
CountryGB
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)56.30
P/E (Forward)16.60
PEG4.74
EV/EBITDA18.13
EV/Revenue2.93
P/S2.68
P/B2.34
EPS (TTM)0.05
EPS (Forward)0.17
52W Range
0.000099% of range284.50
52W High284.50 GBP
52W Low0.0000 GBP
Profitability
Gross Margin53.35%
Oper. Margin10.10%
EBITDA Margin16.18%
Profit Margin4.35%
ROE3.85%
ROA2.52%
Growth
Revenue Growth7.90%
Earnings Growth26.70%
Cash Flow & Leverage
Operating CF41.80M $
CapEx (TTM)16.16M $
FCF Margin4.92%
FCF Yield1.84%
Net Debt81.46M $
Net Debt/EBITDA1.71
Balance Sheet
Debt/Equity0.32
Current Ratio2.79
Quick Ratio1.29
Book Value/Sh1.201 GBP
Cash/Share0.0840 GBP
Dividends
Fwd Div Rate0.0300 GBP
Trail. Div Rate0.0290 GBP
Div. Yield1.02%
5Y Avg Yield0.97%
Payout Ratio59.29%
Ex-Div DateMay 28, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)290.00 GBP
Upside (mean)+3.0%
Target Range275.00 GBP – 325.00 GBP
GBP275.00+3.0% to meanGBP325.00
# Analysts7
Ownership
Shares Out.217.60M
Float189.85M
Insiders7.75%
Institutions77.33%
Technical
SMA 50269.59 (+4.4%)
SMA 200230.29 (+22.2%)
Beta0.70
S&P 52W Chg18.16%
Avg Vol (30d)1.64M
Avg Vol (10d)2.43M
Technical Indicators
RSI (14)70.3
MACD4.1076
MACD Signal5.4534
MACD Hist.-1.3458
BB Upper281.84 GBP
BB Middle280.55 GBP
BB Lower279.26 GBP
BB Width0.92%
ATR (14)2.479 GBP
Vol Ratio (20d)1.08x